tp63 Antibody, HRP conjugated

Shipped with Ice Packs
In Stock

Description

TP63 Antibody: Core Characteristics

TP63 antibodies target isoforms of the TP63 protein, which functions as a transcriptional activator or repressor depending on isoform composition . HRP conjugation amplifies signal detection in assays, making it indispensable for visualizing low-abundance targets.

Key Features of HRP-Conjugated TP63 Antibodies:

PropertyDetailsSources
Host SpeciesMouse, Rabbit (monoclonal and polyclonal variants)
ClonalityMonoclonal (e.g., clones 3F2B8D11, 10H7L17) and Polyclonal
ReactivitiesHuman, Mouse, Zebrafish, Southern platyfish, Bovine
ApplicationsWB, IHC, IHC-Fr (frozen), IHC-Wm (whole mount), ChIP, ICC, Flow Cytometry
Molecular WeightDetects isoforms ranging from 44.7 kDa to 76.8 kDa
Dilution RangeWB: 1:250–1:10,000; IHC: 1:50–1:200

Mechanistic Insights

TP63 regulates genes involved in epithelial morphogenesis, limb development, and tumor suppression. HRP-conjugated antibodies have been pivotal in studies demonstrating:

  • Ferroptosis Suppression: TP63 upregulates SLC7A5 in head and neck squamous cell carcinoma (HNSCC), inhibiting ferroptosis (iron-dependent cell death) and promoting therapy resistance .

  • Cancer Biomarker Potential: Overexpression correlates with poor prognosis in esophageal squamous cell carcinoma (ESCC) and HNSCC .

  • Isoform-Specific Roles: ΔN isoforms dominate in epithelial stem cells, while TA isoforms drive apoptosis in response to DNA damage .

A. Western Blot Performance

  • Zebrafish Tissue: Detected TP63 at ~43–52 kDa using a 1:2,500 dilution .

  • Recombinant Protein: Validated specificity using E. coli-expressed TP63 (~91 kDa with tags) .

B. IHC Applications

  • Esophageal Cancer: Strong nuclear staining in recurrent ESCC tissues, correlating with poor survival .

  • Prostate and Lung Cancer: Distinct TP63 expression in basal epithelial layers .

C. Flow Cytometry

  • A431 Cells: Intracellular staining confirmed TP63 expression in permeabilized cells .

Research Implications

  • Therapeutic Targeting: TP63-mediated SLC7A5 upregulation in HNSCC highlights a pathway for overcoming immunotherapy resistance .

  • Diagnostic Utility: High TP63 expression in ESCC recurrence suggests its role as a prognostic biomarker .

  • Technical Limitations: Small sample sizes in single-cell studies and incomplete mechanistic validation require further investigation .

Protocol Optimization

  • Blocking: 5% non-fat milk in PBST reduces background in WB .

  • Antigen Retrieval: EDTA buffer (pH 8.0) enhances IHC signal in paraffin-embedded tissues .

  • Controls: Anti-thio tags (for recombinant proteins) and isotype-matched antibodies ensure specificity .

Future Directions

  • Functional Studies: Delineate TP63’s role in ferroptosis via CRISPR or siRNA knockdown .

  • Clinical Trials: Validate TP63 as a companion diagnostic for anti-PD-1/PD-L1 therapies in HNSCC .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
We typically dispatch orders within 1-3 business days of receipt. Delivery times may vary depending on the purchasing method and location. For specific delivery timelines, please consult your local distributors.
Target Names
Uniprot No.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.